Sorry, the video which you have requested is not yet processed.

Filter By:
http://cance... Acquired Resistance Forum Video #7: Speakers from videos #5 and #6 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West. GRACEcast 280 Lung
by:cancergrace | 14 views
Download from iTunes: https://itun... Wilms’ tumor is a cancer that develops in the kidney and is the fifth most common cancer in children. Generally there are no symptoms and Wilms’ tumor is most likely discovered when a large mass is felt by a parent. Najat Daw, M.D...
by:mdanderson | 11 views
http://cance... Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy. GRACEcast 279 Lung
by:cancergrace | 56 views
What are the expectations for patients undergoing surgery for pancreatic cancer? Dr. A. James Moser of Beth Israel Deaconess Medical Center helps us understand why this is such a tough question and how he and his team counsel patients, particularly those fearful of undergoing surgery of any kind. Listen as Dr. Moser talks about the dramatic upswing...
by:patientpower | 85 views
What is the JAK2 mutation? What is a JAK inhibitor, and how does it work? Dr. Brady Stein, an MPN expert from Northwestern Medicine, explains what JAK2 is and how this gene relates to myeloproliferat​ive neoplasms (MPNs). He also describes JAK inhibitors, like ruxolitinib (Jakafi®), and the role that these agents play in the treatment of MPNs. Ge...
by:patientpower | 73 views
In the recent past, lymphoma researchers have turned their attention to a phenomenon known as the “microenvironme​nt.” Made up of three factors, the microenvironmen​t involves healthy cells adjacent to the cancerous ones and helps keep the lymphoma alive in the face of treatment with chemotherapy. By releasing natural checks on the human immune syste...
by:patientpower | 84 views
The newest lymphoma drugs are very expensive and some patients may takes them for years. How can we afford these therapies. Experts share their views in this roundtable discussion. Get email alerts | http://www.p... Subscribe on YouTube | http://www.y... Like on Facebook | http://www.f.......
by:patientpower | 85 views
Today's cancer interdisciplina​ry teams are different from before. And just as there are new combinations of doctors, there are new combinations of medicines. Our roundtable of experts explains what this means for patients today. Get email alerts | http://www.p... Subsc...
by:patientpower | 64 views
http://cance... Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies. GRACEcast 278 Lung
by:cancergrace | 92 views
Where do MPNs come from? Do environmental factors influence whether you will get an MPN? Dr. Alison Moliterno from Johns Hopkins Medicine explains researchers' discoveries about chemical exposure and other environmental factors related to the incidence of MPNs. Get email alerts | http://www.p... Subscribe on YouTube &...
by:patientpower | 66 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)